Exclusive
Most Read
Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says
Former Medicare leader Seema Verma joins board of health tech firm Lumeris
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant
The Trump administration quietly spent billions in hospital funds on Operation Warp Speed
Covid-19 vaccination rates follow the money in states with the biggest wealth gaps, analysis shows
The history of OxyContin, told through unsealed Purdue documents
Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
All Coverage
advertisement
